share_log

Tilray Brands | DEFA14A: Others

Tilray Brands | DEFA14A: Others

Tilray Brands | DEFA14A：其他
美股SEC公告 ·  2024/11/06 16:05

Moomoo AI 已提取核心信息

On October 31, 2024, a class action complaint was filed against Tilray Brands, Inc. by Nabil Salama on behalf of a putative class of stockholders, with Tilray and its Board of Directors named as defendants. The complaint alleges that the proxy statements filed for Tilray's 2023 and 2024 Annual Meetings of Stockholders contained inaccuracies regarding the voting standard and the effect of abstentions and broker non-votes on proposals to increase the number of authorized shares of common stock. The plaintiff contends that the proposals were not validly approved under the majority-of-votes-cast standard as claimed, but rather required a majority-of-outstanding-shares voting standard as per the company's charter. Tilray disagrees with the allegations and intends to defend...Show More
On October 31, 2024, a class action complaint was filed against Tilray Brands, Inc. by Nabil Salama on behalf of a putative class of stockholders, with Tilray and its Board of Directors named as defendants. The complaint alleges that the proxy statements filed for Tilray's 2023 and 2024 Annual Meetings of Stockholders contained inaccuracies regarding the voting standard and the effect of abstentions and broker non-votes on proposals to increase the number of authorized shares of common stock. The plaintiff contends that the proposals were not validly approved under the majority-of-votes-cast standard as claimed, but rather required a majority-of-outstanding-shares voting standard as per the company's charter. Tilray disagrees with the allegations and intends to defend against the action vigorously, asserting that the voting standard used was consistent with Delaware law. The plaintiff seeks to prevent the upcoming vote on the 2024 Authorized Shares Proposal and requests that costs and expenses be awarded to the class. The case highlights the importance of accurate disclosures in proxy statements and the legal standards for stockholder approval of corporate actions.
2024年10月31日，Nabil Salama代表一群股东针对tilray brands公司提起集体诉讼，指控Tilray及其董事会为被告。诉状称，Tilray在2023和2024年股东年会的代理声明中包含了关于投票标准、弃权和经纪人不投票对增加普通股授权股份提案的影响方面的不准确信息。原告主张，这些提案并未按照所称的投票份额标准得到有效批准，而是按照公司章程规定的股票绝大多数标准要求批准。Tilray对这些指控表示异议，并打算强力辩护，声称所使用的投票标准与特拉华州法律一致。原告寻求阻止对2024年授权股份提案的即将投票，并要求向该类股派发成本和费用。该案件凸显了代理声明中准确披露信息以及股东对公司行动批准的法律标准的重要性。
2024年10月31日，Nabil Salama代表一群股东针对tilray brands公司提起集体诉讼，指控Tilray及其董事会为被告。诉状称，Tilray在2023和2024年股东年会的代理声明中包含了关于投票标准、弃权和经纪人不投票对增加普通股授权股份提案的影响方面的不准确信息。原告主张，这些提案并未按照所称的投票份额标准得到有效批准，而是按照公司章程规定的股票绝大多数标准要求批准。Tilray对这些指控表示异议，并打算强力辩护，声称所使用的投票标准与特拉华州法律一致。原告寻求阻止对2024年授权股份提案的即将投票，并要求向该类股派发成本和费用。该案件凸显了代理声明中准确披露信息以及股东对公司行动批准的法律标准的重要性。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    相关股票 相关股票
    代码 迷你走势 最新价
    Quantum BioPharma
    QNTM
    -- 8.380
    大自然药业
    UPC
    -- 5.3600
    惠普森医药
    CPHI
    -- 0.2903
    Tilray Brands
    TLRY
    -- 0.714
    和黄医药
    HCM
    -- 15.260
    解锁完整榜单
    重估中国资产
    继中国开创性的DeepSeek技术推出之后， 华尔街大行重估对中国市场的投资前景。
    热门讨论
    中概股财报季火热：惊喜盈利能否延续涨势？
    1. 哪些行业可能成为本轮中概股财报季的市场焦点？ 2. 在政府强调科技创新和可持续发展的背景下，你认为哪些行业具有最大的增长潜力？ 展开
    中国两会：会议前后股票价格走势的主要要点